pamidronate has been researched along with Maxillary Diseases in 17 studies
Maxillary Diseases: Diseases involving the MAXILLA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of this study was to evaluate a possible role of microcracks in the pathogenesis of bisphosphonate-related osteonecrosis of the jaw (ONJ) and to discuss an etiological model." | 7.76 | Importance of microcracks in etiology of bisphosphonate-related osteonecrosis of the jaw: a possible pathogenetic model of symptomatic and non-symptomatic osteonecrosis of the jaw based on scanning electron microscopy findings. ( Eufinger, H; Hoefert, S; Schmitz, I; Tannapfel, A, 2010) |
| "The aim of this study was to evaluate a possible role of microcracks in the pathogenesis of bisphosphonate-related osteonecrosis of the jaw (ONJ) and to discuss an etiological model." | 3.76 | Importance of microcracks in etiology of bisphosphonate-related osteonecrosis of the jaw: a possible pathogenetic model of symptomatic and non-symptomatic osteonecrosis of the jaw based on scanning electron microscopy findings. ( Eufinger, H; Hoefert, S; Schmitz, I; Tannapfel, A, 2010) |
| "The patient had a medical history of breast cancer with bone metastasis that was treated by chemotherapy with 45 mg pamidronate in 2 weekly courses for 16 months." | 1.36 | [A case of breast cancer with extensive osteonecrosis of maxilla induced by a bisphosphonate]. ( Inokuchi, S; Koga, C; Koga, M; Kusukawa, J; Tanaka, Y; Yokomizo, Y, 2010) |
| "Recent cases of bone necrosis of the jaws have been associated with the use of bisphosphonate therapy." | 1.35 | Bisphosphonate-associated osteonecrosis: a clinician's reference to patient management. ( Fayans, EP; Grewal, VS, 2008) |
| "Recent cases of bone necrosis of the jaws have been associated with the use of bisphosphonate therapy." | 1.35 | Bisphosphonate-associated osteonecrosis. A clinician's reference to patient management. ( Fayans, EP; Grewal, VS, 2008) |
| "Over last 10 years, cases of jaw bone necrosis have been associated with the use of bisphosphonate therapy." | 1.33 | Jaw bone necrosis without previous dental extractions associated with the use of bisphosphonates (pamidronate and zoledronate): a four-case report. ( Corradi, D; Manfredi, M; Meleti, M; Merigo, E; Vescovi, P, 2005) |
| " Current reports have focused on therapy-resistant osteonecrosis of the jaws as a possible side effect of bisphosphonates." | 1.33 | [Osteonecrosis of the jaws as a possible adverse effect of the use of bisphosphonates]. ( Eufinger, H; Hoefert, S, 2005) |
| "The reasons for bisphosphonate treatment were multiple myeloma in 12 patients, breast cancer with bone metastasis in four patients and histiocytosis X in one patient." | 1.33 | Osteonecrosis of the jaws and bisphosphonate treatment in cancer patients. ( Baumann, A; Czerny, C; Eisenmenger, G; Ewers, R; Hoffmann, M; Moser, D; Pietschmann, P; Wutzl, A, 2006) |
| "Here we report 29 cases of bone necrosis of the jaws in patients treated with pamidronate (Aredia), zoledronate (Zometa) and alendronate: 15 underwent surgical procedures and 14 occurred spontaneously." | 1.33 | Bone necrosis of the jaws associated with bisphosphonate treatment: a report of twenty-nine cases. ( Bonaninil, M; Corcione, L; Corradi, D; D'Aleo, P; Ferrari, S; Guidotti, R; Manfredi, M; Meleti, M; Merigo, E; Poli, T; Ripasarti, A; Sesenna, E; Vescovi, P; Zanzucchi, E, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 11 (64.71) | 29.6817 |
| 2010's | 6 (35.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grewal, VS | 2 |
| Fayans, EP | 2 |
| Seehra, J | 1 |
| Sloan, P | 1 |
| Oliver, RJ | 1 |
| Stockmann, P | 1 |
| Hinkmann, FM | 1 |
| Lell, MM | 1 |
| Fenner, M | 1 |
| Vairaktaris, E | 1 |
| Neukam, FW | 1 |
| Nkenke, E | 1 |
| Hoefert, S | 2 |
| Schmitz, I | 1 |
| Tannapfel, A | 1 |
| Eufinger, H | 2 |
| Treister, NS | 1 |
| Friedland, B | 1 |
| Woo, SB | 1 |
| Tanaka, Y | 1 |
| Koga, M | 1 |
| Yokomizo, Y | 1 |
| Inokuchi, S | 1 |
| Koga, C | 1 |
| Kusukawa, J | 1 |
| Mast, G | 1 |
| Otto, S | 1 |
| Mücke, T | 1 |
| Schreyer, C | 1 |
| Bissinger, O | 1 |
| Kolk, A | 1 |
| Wolff, KD | 1 |
| Ehrenfeld, M | 1 |
| Stürzenbaum, SR | 1 |
| Pautke, C | 1 |
| Hewson, I | 1 |
| Syme, D | 1 |
| Bruscino-Raiola, F | 1 |
| Carter, G | 1 |
| Goss, AN | 1 |
| Doecke, C | 1 |
| Guarino, MJ | 1 |
| Hill, CE | 1 |
| Patel, K | 1 |
| Merigo, E | 2 |
| Manfredi, M | 2 |
| Meleti, M | 2 |
| Corradi, D | 2 |
| Vescovi, P | 2 |
| Hay, KD | 1 |
| Bishop, PA | 1 |
| Wutzl, A | 1 |
| Eisenmenger, G | 1 |
| Hoffmann, M | 1 |
| Czerny, C | 1 |
| Moser, D | 1 |
| Pietschmann, P | 1 |
| Ewers, R | 1 |
| Baumann, A | 1 |
| Guidotti, R | 1 |
| Ripasarti, A | 1 |
| Zanzucchi, E | 1 |
| D'Aleo, P | 1 |
| Corcione, L | 1 |
| Sesenna, E | 1 |
| Ferrari, S | 1 |
| Poli, T | 1 |
| Bonaninil, M | 1 |
| Gueiros, LA | 1 |
| Lopes, MA | 1 |
| Leão, JC | 1 |
1 trial available for pamidronate and Maxillary Diseases
| Article | Year |
|---|---|
Panoramic radiograph, computed tomography or magnetic resonance imaging. Which imaging technique should be preferred in bisphosphonate-associated osteonecrosis of the jaw? A prospective clinical study.
Topics: Aged; Bone Density Conservation Agents; Bone Marrow; Contrast Media; Diphosphonates; Female; Follow- | 2010 |
16 other studies available for pamidronate and Maxillary Diseases
| Article | Year |
|---|---|
Bisphosphonate-associated osteonecrosis: a clinician's reference to patient management.
Topics: Aged, 80 and over; Alveolar Bone Loss; Antineoplastic Agents; Bone Density Conservation Agents; Diph | 2008 |
Paget's disease of bone and osteonecrosis.
Topics: Aged; Bone Density Conservation Agents; Diphosphonates; Dry Socket; Female; Humans; Hypercementosis; | 2009 |
Importance of microcracks in etiology of bisphosphonate-related osteonecrosis of the jaw: a possible pathogenetic model of symptomatic and non-symptomatic osteonecrosis of the jaw based on scanning electron microscopy findings.
Topics: Adult; Aged; Aged, 80 and over; Alendronate; Bone Density Conservation Agents; Connective Tissue; Di | 2010 |
Use of cone-beam computerized tomography for evaluation of bisphosphonate-associated osteonecrosis of the jaws.
Topics: Adult; Aged; Alendronate; Bone Density Conservation Agents; Cone-Beam Computed Tomography; Diphospho | 2010 |
[A case of breast cancer with extensive osteonecrosis of maxilla induced by a bisphosphonate].
Topics: Aged; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Female; Humans; Maxil | 2010 |
Incidence of maxillary sinusitis and oro-antral fistulae in bisphosphonate-related osteonecrosis of the jaw.
Topics: Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Cone-Beam Comp | 2012 |
Radical surgical treatment of bisphosphonate related osteonecrosis of the jaw.
Topics: Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Collagen Type | 2012 |
Bisphosphonates and avascular necrosis of the jaw: a possible association.
Topics: Aged; Aged, 80 and over; Alendronate; Anti-Inflammatory Agents; Diphosphonates; Female; Follow-Up St | 2005 |
Bisphosphonates, cancer, and osteonecrosis--a single practice experience.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocol | 2005 |
Jaw bone necrosis without previous dental extractions associated with the use of bisphosphonates (pamidronate and zoledronate): a four-case report.
Topics: Aged; Anti-Bacterial Agents; Bone Density Conservation Agents; Bone Neoplasms; Curettage; Diphosphon | 2005 |
[Osteonecrosis of the jaws as a possible adverse effect of the use of bisphosphonates].
Topics: Aged; Alendronate; Diphosphonates; Female; Follow-Up Studies; Humans; Imidazoles; Male; Mandibular D | 2005 |
Association of osteonecrosis of the jaws and bisphosphonate pharmacotherapy: dental implications.
Topics: Adenocarcinoma; Aged, 80 and over; Bone Density Conservation Agents; Carcinoma; Diabetes Mellitus, T | 2006 |
Osteonecrosis of the jaws and bisphosphonate treatment in cancer patients.
Topics: Adult; Aged; Biopsy; Bone Density Conservation Agents; Breast Neoplasms; Diphosphonates; Female; Fol | 2006 |
Bone necrosis of the jaws associated with bisphosphonate treatment: a report of twenty-nine cases.
Topics: Aged; Aged, 80 and over; Alendronate; Anti-Bacterial Agents; Antifungal Agents; Bone Density Conserv | 2006 |
Bisphosphonate-associated osteonecrosis. A clinician's reference to patient management.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents, Local; Bone Density Conservation Ag | 2008 |
Paget's disease and bisphosphonate-associated osteonecrosis of the jaws.
Topics: Aged, 80 and over; Bone Density Conservation Agents; Diphosphonates; Humans; Imidazoles; Injections, | 2008 |